Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ICUI's Cash to Debt is ranked higher than
94% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. ICUI: No Debt )
ICUI' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt

Equity to Asset 0.94
ICUI's Equity to Asset is ranked higher than
99% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.57 vs. ICUI: 0.94 )
ICUI' s 10-Year Equity to Asset Range
Min: 0.86   Max: 0.95
Current: 0.94

0.86
0.95
Interest Coverage No Debt
ICUI's Interest Coverage is ranked higher than
89% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.08 vs. ICUI: No Debt )
ICUI' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: 28.08
M-Score: -2.93
WACC vs ROIC
3.78%
15.54%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 12.62
ICUI's Operating margin (%) is ranked higher than
83% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.43 vs. ICUI: 12.62 )
ICUI' s 10-Year Operating margin (%) Range
Min: 7.83   Max: 34.17
Current: 12.62

7.83
34.17
Net-margin (%) 8.52
ICUI's Net-margin (%) is ranked higher than
80% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. ICUI: 8.52 )
ICUI' s 10-Year Net-margin (%) Range
Min: 6.62   Max: 22.42
Current: 8.52

6.62
22.42
ROE (%) 5.43
ICUI's ROE (%) is ranked higher than
72% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.57 vs. ICUI: 5.43 )
ICUI' s 10-Year ROE (%) Range
Min: 3.2   Max: 16.19
Current: 5.43

3.2
16.19
ROA (%) 5.08
ICUI's ROA (%) is ranked higher than
77% of the 313 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. ICUI: 5.08 )
ICUI' s 10-Year ROA (%) Range
Min: 3.04   Max: 14.64
Current: 5.08

3.04
14.64
ROC (Joel Greenblatt) (%) 24.91
ICUI's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.46 vs. ICUI: 24.91 )
ICUI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.82   Max: 74.5
Current: 24.91

8.82
74.5
Revenue Growth (3Y)(%) -2.50
ICUI's Revenue Growth (3Y)(%) is ranked higher than
60% of the 264 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. ICUI: -2.50 )
ICUI' s 10-Year Revenue Growth (3Y)(%) Range
Min: -2.5   Max: 34.6
Current: -2.5

-2.5
34.6
EBITDA Growth (3Y)(%) -14.10
ICUI's EBITDA Growth (3Y)(%) is ranked higher than
55% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. ICUI: -14.10 )
ICUI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -19.8   Max: 35.1
Current: -14.1

-19.8
35.1
EPS Growth (3Y)(%) -18.90
ICUI's EPS Growth (3Y)(%) is ranked higher than
57% of the 229 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. ICUI: -18.90 )
ICUI' s 10-Year EPS Growth (3Y)(%) Range
Min: -32.2   Max: 66
Current: -18.9

-32.2
66
» ICUI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

ICUI Guru Trades in Q1 2014

Steven Cohen 3,930 sh (New)
Joel Greenblatt 242,621 sh (+81.69%)
Mario Gabelli 115,000 sh (+64.91%)
Jim Simons 732,201 sh (+22.34%)
Chuck Royce 700 sh (unchged)
Paul Tudor Jones 4,115 sh (-74.22%)
» More
Q2 2014

ICUI Guru Trades in Q2 2014

Paul Tudor Jones 84,249 sh (+1947.36%)
Mario Gabelli 125,600 sh (+9.22%)
Chuck Royce 700 sh (unchged)
Joel Greenblatt 224,111 sh (-7.63%)
Jim Simons 645,500 sh (-11.84%)
» More
Q3 2014

ICUI Guru Trades in Q3 2014

Paul Tudor Jones 85,463 sh (+1.44%)
Chuck Royce 700 sh (unchged)
Mario Gabelli 122,200 sh (-2.71%)
Jim Simons 557,900 sh (-13.57%)
Joel Greenblatt 118,526 sh (-47.11%)
» More
Q4 2014

ICUI Guru Trades in Q4 2014

Chuck Royce 700 sh (unchged)
Jim Simons 544,741 sh (-2.36%)
Joel Greenblatt 114,420 sh (-3.46%)
Mario Gabelli 113,300 sh (-7.28%)
Paul Tudor Jones 60,600 sh (-29.09%)
» More
» Details

Insider Trades

Latest Guru Trades with ICUI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 52.60
ICUI's P/E(ttm) is ranked higher than
71% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.70 vs. ICUI: 52.60 )
ICUI' s 10-Year P/E(ttm) Range
Min: 13.77   Max: 106.63
Current: 52.6

13.77
106.63
Forward P/E 32.05
ICUI's Forward P/E is ranked higher than
78% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 163.93 vs. ICUI: 32.05 )
N/A
PE(NRI) 52.40
ICUI's PE(NRI) is ranked higher than
76% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.30 vs. ICUI: 52.40 )
ICUI' s 10-Year PE(NRI) Range
Min: 13.78   Max: 106
Current: 52.4

13.78
106
P/B 2.70
ICUI's P/B is ranked higher than
72% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. ICUI: 2.70 )
ICUI' s 10-Year P/B Range
Min: 1.4   Max: 3.22
Current: 2.7

1.4
3.22
P/S 4.47
ICUI's P/S is ranked higher than
51% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.10 vs. ICUI: 4.47 )
ICUI' s 10-Year P/S Range
Min: 1.73   Max: 6.58
Current: 4.47

1.73
6.58
PFCF 32.50
ICUI's PFCF is ranked higher than
77% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 105.70 vs. ICUI: 32.50 )
ICUI' s 10-Year PFCF Range
Min: 11.24   Max: 98.42
Current: 32.5

11.24
98.42
POCF 22.71
ICUI's POCF is ranked higher than
78% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.17 vs. ICUI: 22.71 )
ICUI' s 10-Year POCF Range
Min: 9.22   Max: 30.54
Current: 22.71

9.22
30.54
EV-to-EBIT 26.60
ICUI's EV-to-EBIT is ranked higher than
80% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 36.81 vs. ICUI: 26.60 )
ICUI' s 10-Year EV-to-EBIT Range
Min: 7   Max: 71.3
Current: 26.6

7
71.3
PEG 131.00
ICUI's PEG is ranked higher than
83% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ICUI: 131.00 )
ICUI' s 10-Year PEG Range
Min: 0.6   Max: 799.14
Current: 131

0.6
799.14
Shiller P/E 36.40
ICUI's Shiller P/E is ranked higher than
85% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ICUI: 36.40 )
ICUI' s 10-Year Shiller P/E Range
Min: 16.43   Max: 38.43
Current: 36.4

16.43
38.43
Current Ratio 15.22
ICUI's Current Ratio is ranked higher than
99% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. ICUI: 15.22 )
ICUI' s 10-Year Current Ratio Range
Min: 6.17   Max: 17.85
Current: 15.22

6.17
17.85
Quick Ratio 13.93
ICUI's Quick Ratio is ranked higher than
99% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. ICUI: 13.93 )
ICUI' s 10-Year Quick Ratio Range
Min: 4.94   Max: 17.1
Current: 13.93

4.94
17.1
Days Inventory 85.15
ICUI's Days Inventory is ranked higher than
87% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 135.02 vs. ICUI: 85.15 )
ICUI' s 10-Year Days Inventory Range
Min: 19.11   Max: 101.19
Current: 85.15

19.11
101.19
Days Sales Outstanding 46.09
ICUI's Days Sales Outstanding is ranked higher than
90% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 70.75 vs. ICUI: 46.09 )
ICUI' s 10-Year Days Sales Outstanding Range
Min: 40.82   Max: 84.81
Current: 46.09

40.82
84.81

Valuation & Return

vs
industry
vs
history
Price/Net Cash 4.40
ICUI's Price/Net Cash is ranked higher than
96% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ICUI: 4.40 )
ICUI' s 10-Year Price/Net Cash Range
Min: 3.67   Max: 8.99
Current: 4.4

3.67
8.99
Price/Net Current Asset Value 3.80
ICUI's Price/Net Current Asset Value is ranked higher than
95% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ICUI: 3.80 )
ICUI' s 10-Year Price/Net Current Asset Value Range
Min: 1.85   Max: 5.14
Current: 3.8

1.85
5.14
Price/Tangible Book 2.70
ICUI's Price/Tangible Book is ranked higher than
84% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.70 vs. ICUI: 2.70 )
ICUI' s 10-Year Price/Tangible Book Range
Min: 1.4   Max: 3.63
Current: 2.7

1.4
3.63
Price/DCF (Projected) 1.80
ICUI's Price/DCF (Projected) is ranked higher than
82% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. ICUI: 1.80 )
ICUI' s 10-Year Price/DCF (Projected) Range
Min: 1.01   Max: 2.4
Current: 1.8

1.01
2.4
Price/Median PS Value 1.50
ICUI's Price/Median PS Value is ranked higher than
64% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. ICUI: 1.50 )
ICUI' s 10-Year Price/Median PS Value Range
Min: 0.62   Max: 2.25
Current: 1.5

0.62
2.25
Price/Graham Number 2.50
ICUI's Price/Graham Number is ranked higher than
86% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ICUI: 2.50 )
ICUI' s 10-Year Price/Graham Number Range
Min: 0.93   Max: 2.82
Current: 2.5

0.93
2.82
Earnings Yield (Greenblatt) 3.80
ICUI's Earnings Yield (Greenblatt) is ranked higher than
76% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. ICUI: 3.80 )
ICUI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.4   Max: 14.4
Current: 3.8

1.4
14.4
Forward Rate of Return (Yacktman) 3.01
ICUI's Forward Rate of Return (Yacktman) is ranked higher than
68% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.65 vs. ICUI: 3.01 )
ICUI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.6   Max: 28.2
Current: 3.01

-2.6
28.2

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:IC7.Germany,
ICU Medical, Inc. is a Delaware Corporation founded in 1984 and its initial public offering was in 1992. The Company is engaged in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications. Its products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. The Company's complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needle free infusion connectors, catheters and cardiac monitoring systems. Its products are categorized into three main product lines: Infusion Therapy, Critical Care and Oncology. I.V. therapy lines, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient's vein. The tube typically has several injection ports or Y-sites (conventionally, entry tubes covered by rubber caps) to which a secondary I.V. line can be connected to permit constant intravenous administration of medications, fluids and nutrients, and to allow instantaneous intravenous administration of emergency medication. Critical care products are used to monitor vital signs as well as specific physiological functions of key organ systems and Oncology: Oncology products are used to prepare and deliver hazardous medications such as those used in chemotherapy which, if released, can have harmful effects to the healthcare worker and environment. Manufacturing of its products involves injection molding of plastic and silicone parts, manual and automated assembly of the molded plastic parts, needles and other components, quality control inspection, packaging and sterilization. The Company currently sells all of its products to I.V. product manufacturers, independent distributors and direct sales to the end user. It competes with other manufacturers of closed system transfer devices for the safe handling of oncology drugs, notably Becton Dickinson, CareFusion and B Braun. The Company's products are subject to clearance by the United States Food and Drug Administration ("FDA") under a number of statutes including the Food Drug and Cosmetics Act ("FDC Act").
» More Articles for ICUI

Headlines

Articles On GuruFocus.com
EW: Potential for Capital Appreciation Oct 03 2014 
Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH Mar 10 2014 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 2,388 Shares Nov 29 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 18,831 Shares Nov 24 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,406 Shares Nov 15 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 3,691 Shares Nov 09 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,500 Shares Nov 08 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 5,684 Shares Nov 05 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,000 Shares Nov 03 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 9,496 Shares Nov 02 2010 

More From Other Websites
ICU Medical, Inc. Announces Time of First Quarter 2015 Earnings Call Apr 21 2015
ICU MEDICAL INC/DE Files SEC form 8-K, Financial Statements and Exhibits Apr 21 2015
ICU Medical, Inc. Announces Time of First Quarter 2015 Earnings Call Apr 21 2015
ICU MEDICAL INC/DE Financials Feb 27 2015
Trade Ideas Feb 25 2015
ICU Medical, Inc. to Present at Upcoming Investor Conferences Feb 23 2015
ICU Medical, Inc. to Present at Upcoming Investor Conferences Feb 23 2015
ICU MEDICAL INC/DE Files SEC form 10-K, Annual Report Feb 20 2015
ICU Medical posts 4Q profit Feb 09 2015
ICU Medical posts 4Q profit Feb 09 2015
Medtronic's Pipeline Flex Embolization Device Gets FDA Nod - Analyst Blog Feb 09 2015
ICU Medical Inc Earnings Call scheduled for 4:30 pm ET today Feb 09 2015
ICU MEDICAL INC/DE Files SEC form 8-K, Financial Statements and Exhibits Feb 09 2015
ICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2014 Results Feb 09 2015
Q4 2014 ICU Medical Inc Earnings Release - After Market Close Feb 09 2015
CareFusion Q2 Earnings & Revenues Top Estimates, Up Y/Y - Analyst Blog Feb 06 2015
Boston Scientific Tops Q4 Earnings, Revenues Miss Mark - Analyst Blog Feb 04 2015
Haemonetics Q3 Earnings Top Estimates, Drop Y/Y; Stock Up - Analyst Blog Feb 02 2015
Abaxis (ABAX) Beats Q3 Earnings, Revenues; Margin Grows - Analyst Blog Jan 30 2015
Haemonetics (HAE) in Focus: Stock Adds 6.8% in Session - Tale of the Tape Jan 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK